S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TTNP Titan Pharmaceuticals Inc

6.35

0.00 (0.00%)

Pre Market

Last Updated: 21:00:05

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Titan Pharmaceuticals (NASDAQ:TTNP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Titan Pharmaceuticals Charts.

Titan Pharmaceuticals (NASDAQ:TTNP)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Titan Pharmaceuticals Charts.

Titan Pharmaceuticals Inc News

Form 8-K - Current report
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
Friday 26 January 2024 (6 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 19 January 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 9 January 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 29 December 2023 (7 months ago) • Edgar (US Regulatory)

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
Friday 29 December 2023 (7 months ago) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Wednesday 29 November 2023 (8 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Saturday 18 November 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 16 November 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 October 2023 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 October 2023 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 October 2023 (9 months ago) • Edgar (US Regulatory)

More Titan Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions